Lysine

Lysine

SCHEMBL6444907

NCCCC[C@H](N)C(=O)[O-].O=C(O)O.[Na+]

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GSR P00390 1/20 0.63
▸ RNPEP Q9H4A4 1/20 0.45
▸ CPB2 Q96IY4 2/20 0.41
▸ GNAI3 P08754 1/20 0.41
▸ GNAO1 P09471 1/20 0.41
▸ GNAI1 P63096 1/20 0.41
▸ DPP7 Q9UHL4 7/20 0.40
▸ DPP8 Q6V1X1 3/20 0.40
▸ DPP9 Q86TI2 3/20 0.40
▸ DPP4 P27487 1/20 0.40
▸ MMP2 P08253 1/20 0.39
▸ ARG1 P05089 3/20 0.38
▸ ARG2 P78540 3/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ NFKB1 P19838 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL5062296 0.96 GSR (0.61) GSRRNPEPCPB2GNAI3GNAO1
Lysine SCHEMBL5062299 0.96 GSR (0.61) GSRRNPEPCPB2GNAI3GNAO1
Lysine SCHEMBL1281704 0.96 GSR (0.61) GSRRNPEPCPB2GNAI3GNAO1
Lysine SCHEMBL1281705 0.96 GSR (0.61) GSRRNPEPCPB2GNAI3GNAO1
Lysine SCHEMBL3213815 0.92 GSR (0.77) GSRRNPEPCPB2ARG1ARG2
Lysine SCHEMBL25283016 0.91 GSR (0.61) GSRRNPEPCPB2GNAI3GNAO1
Lysine SCHEMBL5691386 0.91 GSR (0.61) GSRRNPEPCPB2GNAI3GNAO1
Lysine SCHEMBL121844 0.91 GSR (0.61) GSRRNPEPCPB2GNAI3GNAO1
Lysine SCHEMBL3749535 0.91 GSR (0.61) GSRRNPEPCPB2GNAI3GNAO1
Lysine SCHEMBL5691382 0.91 GSR (0.61) GSRRNPEPCPB2GNAI3GNAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040136911-A1 Extended-linear polymeric contrast agents, and synthesizing methods, for medical imaging UZGIRIS EGIDIJUS EDWARD (US) 2004-07-15 — — US claimed
US-20010028876-A1 Extended-linear polymeric contrast agents, and synthesizing methods, for medical imaging GENERAL ELECTRIC COMPANY 2001-10-11 — — US claimed
WO-2005087273-A2 EXTENDED-LINEAR POLYMERIC CONTRAST AGENTS AND THEIR SYNTHESIS GENERAL ELECTRIC COMPANY (US) 2005-09-22 — — WO disclosed
US-20040170562-A1 Extended-linear polymeric contrast agents, and synthesizing methods, for medical imaging GENERAL ELECTRIC COMPANY 2004-09-02 — — US disclosed
US-20040136911-A1 Extended-linear polymeric contrast agents, and synthesizing methods, for medical imaging UZGIRIS EGIDIJUS EDWARD (US) 2004-07-15 — — US disclosed
US-6685915-B2 PARAMAGENTIC CHELATE COMPOUNDS; MAGNETIC RESONANCE IMAGING CONTRAST AGENT GENERAL ELECTRIC COMPANY 2004-02-03 — — US disclosed
US-20010028876-A1 Extended-linear polymeric contrast agents, and synthesizing methods, for medical imaging GENERAL ELECTRIC COMPANY 2001-10-11 — — US disclosed
Send feedback